GeoVax Labs, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-21.5M | $-25.0M | $-26.0M | $-14.0M | $-18.6M | $-3.0M | $-2.4M | $-2.6M |
| Depreciation & Amortization | $68.8K | $95.4K | $74.2K | $56.3K | $38.5K | $19.7K | $8.4K | $19.8K |
| Depreciation | $68.8K | $80.4K | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.1M | $528.6K | $1.1M | $902.1K | $370.0K | $64.5K | $327.5K | $469.7K |
| Net Cash from Operating Activities | $-21.5M | $-24.7M | $-25.2M | $-19.0M | $-11.2M | $-2.8M | $-1.4M | $-1.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $27.6K | $20.7K | $48.9K | $134.3K | $47.7K | $156.8K | $7.6K | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-27.6K | $-20.7K | $-48.9K | $-134.3K | $-47.7K | $-156.8K | $-7.6K | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $19.1M | $23.8M | $4.1M | $35.4M | $12.8M | $12.5M | $1.4M | $1.5M |
| Net Change in Cash | $-2.4M | $-945.6K | $-21.2M | $16.2M | $1.5M | $9.6M | $23.6K | $-53.0K |
| Free Cash Flow | $-21.5M | $-24.7M | $-25.2M | $-19.2M | $-11.2M | $-2.9M | $-1.4M | — |